Latest News about MindBio Therapeutics
Recent news which mentions MindBio Therapeutics
Mindbio Announces Intention To Refile MD & A
February 14, 2025
Tickers
MBIO
Mindbio Announces Clinical Trial Milestone In Phase 2B Microdosing Trials Targeting Existential Distress, Depression & Anxiety In Advanced Stage Cancer
October 24, 2024
Tickers
MBIO
LSD Microdosing For PMS? After Confirming Antidepressant Effects, Clinical Trials Will Assess If It Addresses Mood Issues
April 30, 2024
From Benzinga
MindBio Phase 2 LSD-Microdosing Clinical Trial In Patients With Major Depressive Disorder Begins Pre-Screening Participants
July 19, 2023
From Benzinga
Psychedelics Investment Holder Blackhawk Growth Hosts Meeting For Potential Subsidiary Spin-Out
November 09, 2022
Tickers
BLRZF
From Benzinga
LSD Microdosing Yields Positive Outcomes In Phase 1 Study, More Trials On Depression & Existential Distress
November 04, 2022
Tickers
BLRZF
From Benzinga
Recap: Blackhawk Growth Fund's Most Recent Business Highlights, From Retail Sales To Phase 2 Clinical Trials
August 10, 2022
Tickers
BLRZF
From Benzinga
The World's Largest Microdosing Clinical Trial Has Been Completed, Here Are The Results
May 04, 2022
Tickers
BLRZF
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.